Hypertension While Lying Down Tied to Worse Cardiovascular Disease Outcomes
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, Sept. 13, 2023 -- Having hypertension while in a supine position is associated with a higher risk for cardiovascular disease (CVD), CVD-related events, and death, according to a study presented at the American Heart Association Hypertension 2023 Scientific Sessions, held from Sept. 7 to 10 in Boston.
Duc M. Giao, from Harvard Medical School in Boston, and colleagues examined whether hypertension while supine in clinic is a risk factor for CVD independent of seated blood pressure. The analysis included 11,369 participants in the Atherosclerosis Risk in Communities Study (1987 to 1989) followed for a median of 25 to 28 years.
The researchers found that when adjusting for seated hypertension, supine hypertension was associated with incident coronary heart disease (hazard ratio [HR], 1.60), heart failure (HR, 1.83), stroke (HR, 1.86), fatal coronary heart disease (HR, 2.18), and all-cause mortality (HR, 1.43). Results persisted regardless of hypertension medication use. Risk for participants with supine hypertension alone was similar to hypertension in both positions.
"Our findings suggest people with known risk factors for heart disease and stroke may benefit from having their blood pressure checked while lying flat on their backs," Giao said in a statement. "Efforts to manage blood pressure during daily life may help lower blood pressure while sleeping. Future research should compare supine blood pressure measurements in the clinic with overnight measurements."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
HTN, Albuminuria Risks No Worse for Kidney Donors Versus Nondonors
THURSDAY, May 30, 2024 -- Living kidney donors and nondonors have similar risks for hypertension and albuminuria, according to a study published online May 23 in the Journal of...
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.